Butterfly Network to Participate at Oppenheimer 35th Annual Healthcare MedTech Conference
Generado por agente de IAMarcus Lee
miércoles, 5 de marzo de 2025, 8:12 am ET1 min de lectura
BFLY--
Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the Virtual OppenheimerOPY-- 35th Annual Healthcare MedTechMED-- & Services Conference on March 18, 2025. Joseph DeVivoDIVO--, President, Chief Executive Officer & Chairman and Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one investor meetings and take part in a Fireside Chat at 11:20am EDT.
A webcast of the Fireside Chat will be available in the Events & Presentations section of the Butterfly investor website. To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz, please reach out to your Oppenheimer representative.
Butterfly Network's participation in the conference aligns with its long-term growth strategy, offering an opportunity to connect with potential investors, update them on the company's progress, and potentially secure new funding. The conference also provides a platform for the company to explore strategic partnerships and collaborations, thought leadership, and market intelligence.

Butterfly Network has been making waves in the medical imaging industry with its innovative handheld ultrasound devices, such as the Butterfly iQ. The company's commitment to making medical imaging more accessible, affordable, and intelligent has earned it recognition from industry experts and investors alike. With a market value of over $12 billion, Butterfly NetworkBFLY-- is well-positioned to continue its growth trajectory.
As the company continues to innovate and expand its product offerings, investors can expect updates on its financial performance, product roadmap, market expansion, and strategic partnerships at the upcoming conference. Butterfly Network's participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference is a testament to its commitment to driving growth and innovation in the medical imaging industry.
DIVO--
MED--
OPY--
Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the Virtual OppenheimerOPY-- 35th Annual Healthcare MedTechMED-- & Services Conference on March 18, 2025. Joseph DeVivoDIVO--, President, Chief Executive Officer & Chairman and Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one investor meetings and take part in a Fireside Chat at 11:20am EDT.
A webcast of the Fireside Chat will be available in the Events & Presentations section of the Butterfly investor website. To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz, please reach out to your Oppenheimer representative.
Butterfly Network's participation in the conference aligns with its long-term growth strategy, offering an opportunity to connect with potential investors, update them on the company's progress, and potentially secure new funding. The conference also provides a platform for the company to explore strategic partnerships and collaborations, thought leadership, and market intelligence.

Butterfly Network has been making waves in the medical imaging industry with its innovative handheld ultrasound devices, such as the Butterfly iQ. The company's commitment to making medical imaging more accessible, affordable, and intelligent has earned it recognition from industry experts and investors alike. With a market value of over $12 billion, Butterfly NetworkBFLY-- is well-positioned to continue its growth trajectory.
As the company continues to innovate and expand its product offerings, investors can expect updates on its financial performance, product roadmap, market expansion, and strategic partnerships at the upcoming conference. Butterfly Network's participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference is a testament to its commitment to driving growth and innovation in the medical imaging industry.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios